Skip to main content
. 2016 May 3;17(5):665. doi: 10.3390/ijms17050665

Figure 4.

Figure 4

Significantly-altered circulating miRNAs (fold-change >2; p < 0.05) at individual time points during disease progression at hyperinsulinemia (HI), β cell failure (BCF) and late-stage diabetes (LSD) analyzed by qRT-PCR. Log2-fold changes of increased or decreased miRNA species at HI, BCF and LSD are indicated. Each time point was compared to the baseline (week 6 of age).